Wen Ruiting

Pharmacist Deputy Director, Master Supervisor

Research Interests: individualized dosing in critically ill patients, rational use of antimicrobial agents

Tel: +86-10-88325752

Email: tzwxm@bjmu.edu.cn

EDUCATION

Doctor of Pharmacology, Peking University (2012)

Bachelor of English, Huazhong University of Science and Technology (2007)

Bachelor of Clinical Medicine, Wuhan University (2007)

PROFESSIONAL EXPERIENCE

2012 - present    Peking University People’s Hospital, Department of Pharmacy

• Pharmacist Deputy Director (2017)

• Pharmacist in Charge (2012)

2017 - present    Peking University, Department of Pharmacy Administration and Clinical Pharmacy

• Master Supervisor (2017)

2017.3 – 2017.6   West Virginia University 

• Visiting Scholar

ACADEMIC APPOINTMENTS

International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Young Scientist (2024)

Quantitaive Pharmacology Committee of Chinese Pharmacology Society, member (2023)

China Medicine Education Association, Society of Clinical Cancer Research, member (2021)

AWARDS AND CERTIFICATES

Outstanding Clinical Pharmacist, Peking University People’s Hospital (2025)

China Pharmaceutical Association Servier Young Pharmacists’ Award (2019)

REPRESENTATIVE PUBLICATIONS

1. Wen RT, Ni WT, Gu XT, Liu BY, Bai GL, Zhang XH*. Therapeutic Drug Monitoring-Guided Antifungal Therapy Under Tyrosine Kinase Inhibitor Treatment in an Advanced Osteosarcoma Patient with Invasive Pulmonary Aspergillosis. Infect Dug Resist. 2025;18: 6973-6978.

2. Bai GL, Qi H, Huang YQ, Zhang J, Zhao HY, Wen RT*, Zhang XH. Predictive Performance of Bayesian Dosing Software for Vancomycin in Intensive Care Unit Patients. Ther Drug Monit. 2025; 47(5):594-602.

3. Huang YQ#, Wen RT#*, Li XT, Zhang J, Yu ZY, Feng YF*. The Protective Effect of Dexmedetomidine Against Ischemia-Reperfusion Injury after Hepatectomy: A Meta-Analysis of Randomized Controlled Trials. Frontier in Pharmacology. 2021;12:1-13.

4. Wen RT, Zhang FF, Zhang HT. Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder. Psychopharmacology (Berl). 2018;235(6): 1793-1805.

5. Wen RT, Liang JH, Zhang HT. Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence. Advances in Neurobiology 17. Phosphodiesterases: CNS Functions and Diseases. 2017;17:413-444.

6. Gong MF#, Wen RT#, Xu Y#, Pan JC, Fei N, Zhou YM, Xu JP, Liang JH, Zhang HT. Attenuation of ethanol abstinence-induced anxiety and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents. Psychopharmacology (Berl). 2017;234(20):3143-3151.